TRIO Pharmaceuticals
New York, United States· Est. 2017
TRIO pharmaceuticals is developing novel dual targeting antibody drugs to treat cancer by reducing toxicity and increasing immune response to fight against cancer more effectively.
Private Company
Funding information not available
About
TRIO pharmaceuticals is developing novel dual targeting antibody drugs to treat cancer by reducing toxicity and increasing immune response to fight against cancer more effectively.
AntibodiesBiologics